Safety and pharmacokinetics (PK) of AMG 479 in combination with erlotinib (E) or sorafenib (S) in patients (pts) with advanced solid tumors.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: I. Puzanov, J. Sarantopoulos, J. Gilbert, D. Mahalingam, L. I. Chap, H. Deng, M. Zhu, I. McCaffery, G. R. Friberg, L. S. Rosen
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2246205454
